Who We Are

Genekor Medical S.A. is a multinational company, which consists of a network of molecular biology laboratories. We specialize in the development and conduct of molecular analyses / molecular tests for the diagnosis, prognosis and management of diseases, such as cancer, cardiovascular diseases and neurological disorders, using a state-of-the-art technology. Our aim is to empower physicians in applying precision medicine to their patients. Genekor was founded in 2007 and operates four different divisions:

  • Department of Research and Development of Molecular Analyses
  • Department of Molecular Analyses
  • Department of Bioinformatics
  • Department of Scientific Support and Genetic Counseling


Our goal at Genekor Medical S.A. is to revolutionize the personalized treatment of patients by developing and offering highly sensitive and specific molecular assays that are applicable in routine clinical practice, incorporating state-of-the-art technology and assisting physicians in applying cutting edge tools for individualized medicine worldwide.



Genekor is constantly evolving, developing and investing in state-of-the-art equipment, providing specialized services in the field of Molecular Genetics to the global market.


The Management and the Scientific Team of GeneKor Medical S.A are focused on providing the highest quality of reliable Molecular Assays.

  • The specialized laboratories of GeneKor Medical S.A. are accredited by the Hellenic Accreditation Systems S.A (ESYD) under the terms of the ELOT EN ISO 15189:2012 (Cert. No. 822) as they appear in the respective annexes of O.S.O.A. (Official Scope of Accreditation).
  • GeneKor Medical SA is certified according to ISO 9001:2015 (Cert. No. 041150049) and according to ELOT ISO/IEC 27001:2013 (Cert. No. 048190009) by TUV NORD HELLAS.
  • GENEKOR Medical S.A participates in external quality control programs to ensure the high quality provision of molecular assays.


More specifically, GENEKOR Medical S.A participates in external quality control programmes for:

  • Mutation analysis in BRCA1 & BRCA2 genes (Breast Cancer susceptibility genes 1 and 2) – EMQN & CAP
  • Somatic mutation analysis ( EGFR, BRAF, KRAS, KIT, NRAS, HRAS & PDGFRA genes)– EMQN- GenQA-CAP
  • Analysis of Microsatellite Instability (MSI) – GenQA
  • Detection and quantification of the ALK gene rearrangements – UKNEQAS (ICC&ISH)
  • Detection and quantification of the overexpression of the HER2/NEU gene – UKNEQAS (ICC&ISH)

Clinical Specialization

The clinical expertise of Genekor focuses on:
  • Molecular response profile to treatment

  • Determination of hereditary syndromes

  • Pharmacogenomics

  • Scientific support and genetic counseling



"Genekor Medical S.A. has proven to be a valuable partner. They have a deep knowledge and experience in molecular medicine for cancer, as well as an understanding for the physician’s needs and demands. They provide prompt, thorough and reliable results. "

Dr. Vassilios Venizelos

Specialty: Breast Surgeon - Mastology Specialist
Position: Head of Breast Unit METROPOLITAN Hospital
Director of Breast Surgery Clinic METROPOLITAN Hospital
President of the Hellenic Breast Surgery Society

"I have been working with Genekor for over 15 years. I fully trust them because they use very up-to-date technologies and methods, that make the results I receive truly reliable. One of Genekor’s advantages is the detailed and explicit reports and the ongoing scientific support that are very helpful and much appreciated. Everyday collaboration in the process of samples and the web based immediate information of the results is also worth mentioning. Last but not least, they are always willing to support related research, training and educational projects."

Dr. Christos J.Markopoulos

Professor of Surgery – Athens University Medical School
President: UEMS – EBS - Division of Breast Surgery

"Genekor Medical S.A. is the company I trust when I deal with patients with complicated cancer cases. The procedures and the reports are very professional and thorough, but also straightforward and quick. They show a genuine interest for the patient and the physician they work with. "

Dr. Paris Kosmidis

Position: Head of B. Pathology-Oncology Unit at Hygeia
Hospital Director of Scientific Board at Hygeia Hospital

"“Genekor’s experience in cancer molecular testing and reporting has made the implementation of precision medicine in the everyday clinical practice easier and more consistent. I definitely recommend Genekor Medical for the genetic testing required, especially when dealing with aggressive and rare cancers.”

Athena Christopoulou, MD,PhD

Position: Head of Pathology-Oncology Unit at St. Andreas
Hospital of Patras

“Genekor’s reliability and consistency are the reasons I have been collaborating with this company for more than 9 years. I trust the results, because of the technology and the confirmation techniques they use reassure me of their validity. Also, the scientific consultants are constantly available for help during the test procedure, but also after the results, in order to help with any interpretation needed.”

Mircea GONGU, MD

Position: Chief of works, Oncology department, MEDEUROPA Bucharest

“Genekor always delivers thorough and articulate reports. Also, they work closely with the physician in every step of the patient’s testing process and after the report has been distributed.”

Gabriel Cristian VIISOREANU, MD

Position: Chief of works, Oncology Surgeon, Private Breast Institute MONZA